title: Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
abstract: An isoenzyme of pyruvate kinase (Tu M2-PK) is overexpressed by tumor cells and can be measured in blood by a specific immunoenzymatic assay. Our objective was to investigate the diagnostic value of Tu M2-PK in comparison with that of CA 19-9 in pancreatic cancer. We studied 265 subjects: 60 with histologically confirmed pancreatic cancer, 43 with benign pancreatic diseases (acute and chronic pancreatitis), 5 with benign cystic neoplasms of the pancreas, 9 with neuroendocrine tumors, 77 with other abdominal malignancies, 47 with benign digestive diseases, and 24 healthy controls. Levels of plasma Tu M2-PK and serum CA 19-9 were determined by commercially available specific immunoassays. The diagnostic sensitivity and specificity of Tu M2-PK for pancreatic cancer were 85 and 41%, respectively, while those of CA 19-9 were 75 and 81%. The combination of the two tests significantly increased sensitivity (97%) but lowered specificity (38%). In discriminating between pancreatic cancer and acute or chronic pancreatitis, Tu M2-PK turned out to be less accurate than CA 19-9. In patients without pancreatic tumor, cholestasis appeared not to affect the values of Tu M2-PK, while CA 19-9 was found to be significantly higher. Tu M2-PK was also abnormally high in the majority of patients with other digestive malignancies or neuroendocrine tumors. The results demonstrate that Tu M2-PK has a satisfactory sensitivity but a poor specificity in the diagnosis of pancreatic cancer. Used together with CA 19-9, the sensitivity increases considerably.
authors.affiliation: Department of Internal Medicine, Bentivoglio Hospital, Bentivoglio (BO), Italy. maurizio.ventrucci@auslbonord.regione.emilia-romagna.it
authors.forename: Maurizio
authors.initials: M
authors.lastname: Ventrucci
authors.forename: Antonio
authors.initials: A
authors.lastname: Cipolla
authors.forename: Chiara
authors.initials: C
authors.lastname: Racchini
authors.forename: Riccardo
authors.initials: R
authors.lastname: Casadei
authors.forename: Patrizia
authors.initials: P
authors.lastname: Simoni
authors.forename: Lucio
authors.initials: L
authors.lastname: Gullo
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood; D002908:Chronic Disease; D018293:Cystadenoma, Serous / Q000097:blood; D004066:Digestive System Diseases / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000175:diagnosis*; D010195:Pancreatitis / Q000097:blood; D011770:Pyruvate Kinase / Q000097:blood*; D012372:ROC Curve; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D011770:Pyruvate Kinase